FTC Challenges Illumina’s Proposed Acquisition of Cancer Detection Test Maker Grail
Date
The Federal Trade Commission has filed an administrative complaint and authorized a federal court lawsuit to block Illumina’s $7.1 billion proposed acquisition of Grail—a maker of a non-invasive...